Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada

NCT01557400 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy
Becker Muscular Dystrophy
Dystrophinopathy

Interventions

DRUG: Ataluren

Sponsor

PTC Therapeutics